Adenosine A2A receptor (ADORA2A ); ecto-5′-nucleotidase (NT5E; NT; CD73) BriefCommunication Pages: 861 - 861
Rho-associated coiled-coil containing protein kinase 1 (ROCK1); ROCK2 BriefCommunication Pages: 862 - 862
Peroxisomal reductase activating PPARγ (PexRAP); peroxisome proliferation–activated receptor-γ (PPARG; PPARγ) BriefCommunication Pages: 866 - 866
Tumor necrosis factor-α–induced protein 8–like 2 (TNFAIP8L2; TIPE2) BriefCommunication Pages: 872 - 872
Assay measuring impact of secreted proteins on kinase inhibitor sensitivity in human tumor–derived cell lines BriefCommunication Pages: 875 - 875
In situ monitoring of dopamine metabolism to identify improved monoamine oxidase (MAO) inhibitors BriefCommunication Pages: 876 - 876
Metabochip custom genotyping arrays for detection of disease-associated SNP markers BriefCommunication Pages: 877 - 877
Induced pluripotent stem (iPS) cell–derived motor neurons from patients with familial amyotrophic lateral sclerosis (ALS) for in vitro therapeutic screening BriefCommunication Pages: 881 - 881
Mouse model of systemic lupus erythematosus (SLE) induced by nucleic acid–containing amyloid fibrils BriefCommunication Pages: 882 - 882
Expression of herpes simplex virus (HSV) thymidine kinase in human embryonic stem cells (hESCs) as a strategy to prevent teratoma formation BriefCommunication Pages: 883 - 883
Fluorescent cellular assays that monitor protein tyrosine phosphatase activity BriefCommunication Pages: 884 - 884
VEGF-containing, self-assembling peptide nanofiber scaffolds for promoting arteriogenesis BriefCommunication Pages: 886 - 886